Hemrajani Rekha
ALX Oncology Holdings Inc. · Director
Hemrajani Rekha is listed in public filings as director. This Hemrajani Rekha insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include ALX Oncology Holdings Inc. (ALXO), MaxCyte, Inc. (MXCT), and BioAge Labs, Inc. (BIOA). Investors use Hemrajani Rekha's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $53k40.4k shares | Grant / ExerciseJan 20, 2026 | $53.3K40.4k shares | $1.32 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $84k39.9k shares | SellJun 25, 2025 | $22.4K10.7k shares | $2.09 | -- | |
| --50.6k shares | Grant / ExerciseJun 18, 2025 | Disclosure amount unavailable29.2k shares | -- | -- | |
| $107k50.8k shares | Grant / ExerciseJun 18, 2025 | $107.2K50.8k shares | $2.11 | -- | |
| $98k22k shares | Grant / ExerciseJun 5, 2025 | $97.7K22k shares | $4.44 | -- | |
| $67k40.4k shares | Grant / ExerciseJan 21, 2025 | $66.7K40.4k shares | $1.65 | -- | |
| $51k33k shares | BuyDec 2, 2024 | $46.4K30k shares | $1.55 | -- | |
| $54k3k shares | BuySep 27, 2024 | $54.0K3k shares | $18.00 | -- | |
| $170k20.2k shares | Grant / ExerciseJun 13, 2024 | $170.5K20.2k shares | $8.44 | -- | |
| --21.4k shares | Grant / ExerciseJun 11, 2024 | Disclosure amount unavailable21.4k shares | -- | -- | |
| $190k40.7k shares | Grant / ExerciseJun 11, 2024 | $190.5K40.7k shares | $4.68 | -- |